This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Propellon Therapeutics Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Carlos Armando Zepeda-Velazquez
Introduction
Carlos Armando Zepeda-Velazquez is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific protein interactions. With a total of three patents to his name, Zepeda-Velazquez is recognized for his innovative approach to addressing complex biological challenges.
Latest Patents
One of his latest patents focuses on "Substituted carboxamides as inhibitors of WDR5 protein-protein binding." This application is directed to compounds of Formula I, which are designed to inhibit the binding between WDR5 protein and its binding partners. The implications of this research are profound, as these compounds may serve as medicaments for the treatment of various diseases, disorders, or conditions that are mediated by this protein interaction.
Career Highlights
Zepeda-Velazquez is currently associated with Propellon Therapeutics Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on creating effective therapeutic solutions.
Collaborations
Throughout his career, Zepeda-Velazquez has collaborated with talented professionals in the field, including Rima Al-Awar and Gennady Poda. These collaborations have further enriched his research and contributed to the success of his projects.
Conclusion
Carlos Armando Zepeda-Velazquez exemplifies the spirit of innovation in the field of medicinal chemistry. His contributions, particularly in the development of inhibitors for protein interactions, highlight the importance of research in advancing medical science. His work continues to inspire and pave the way for future discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile